Merit Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,478	Closed	-$229K	–	265
2021 Q2	$229K	Buy	2,478 +58	+2%	+$5.36K	0.02%	241
2021 Q1	$215K	Buy	+2,420	New	+$215K	0.02%	221
2020 Q2	–	Sell	-14,538	Closed	-$455K	–	217
2020 Q1	$455K	Buy	+14,538	New	+$455K	0.05%	131